LAUSR

Emerging corticosteroid delivery platforms for treatment of diabetic macular edema

Sign Up to like & get
recommendations!
0 Published in 2020 at "Expert Opinion on Emerging Drugs"

DOI: 10.1080/14728214.2020.1810664

Abstract: ABSTRACT Introduction Diabetic macular edema (DME) is a leading cause of vision impairment. Low-grade inflammation is thought to play a critical role in its pathogenesis. Although vascular endothelial growth factor inhibitors are used first-line, not… read more here.

Keywords: corticosteroid delivery; emerging corticosteroid; delivery; diabetic macular ... See more keywords